Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual

Peter J. Halfmann, Nicholas R. Minor, Luis A. Haddock III, Robert Maddox, Gage K. Moreno, View ORCID ProfileKatarina M. Braun, David A. Baker, Kasen K. Riemersa, Ankur Prasad, Kirsten J. Alman, Matthew C. Lambert, Kelsey Florek, Allen Bateman, Ryan Westergaard, Nasia Safdar, Dave R. Andes, Yoshihiro Kawaoka, Madiha Fida, Joseph D. Yao, View ORCID ProfileThomas C. Friedrich, David H. O’Connor
doi: https://doi.org/10.1101/2022.04.11.22272784
Peter J. Halfmann
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas R. Minor
2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis A. Haddock III
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Maddox
2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gage K. Moreno
2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarina M. Braun
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katarina M. Braun
David A. Baker
2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kasen K. Riemersa
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankur Prasad
3Department of Pulmonary and Critical Care Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsten J. Alman
4Division of Infectious Diseases, Department of Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew C. Lambert
4Division of Infectious Diseases, Department of Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelsey Florek
5Wisconsin State Laboratory of Hygiene, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen Bateman
5Wisconsin State Laboratory of Hygiene, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Westergaard
6Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nasia Safdar
6Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave R. Andes
6Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Kawaoka
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madiha Fida
7Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph D. Yao
8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C. Friedrich
1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas C. Friedrich
David H. O’Connor
2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhoconno@wisc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Prolonged infections in immunocompromised individuals may be a source for novel SARS-CoV-2 variants, particularly when both the immune system and antiviral therapy fail to clear the infection, thereby promoting adaptation. Here we describe an approximately 16-month case of SARS-CoV-2 infection in an immunocompromised individual. Following monotherapy with the monoclonal antibody Bamlanivimab, the individual’s virus was resistant to this antibody via a globally unique Spike amino acid variant (E484T) that evolved from E484A earlier in infection. With the emergence and spread of the Omicron Variant of Concern, which also contains Spike E484A, E484T may arise again as an antibody-resistant derivative of E484A.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part by the National Institutes of Allergy and Infectious Diseases Center for Research on Influenza Pathogenesis (HHSN272201400008C), the Center for Research on Influenza Pathogenesis and Transmission (CRIPT) (75N93021C00014), and by CDC Contract #75D30121C11060. Consensus sequence data was processed using the compute resources and assistance of the UW-Madison Center For High Throughput Computing (CHTC), which is supported by UW-Madison, the Advanced Computing Initiative, the Wisconsin Alumni Research Foundation, the Wisconsin Institutes for Discovery, and the National Science Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Collection and testing of biological specimens and protected health information were performed in concordance with the University of Wisconsin IRB # 2021-0076 following informed consent from the patient.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All scripts, consensus sequence data, and sequencing read data used in the writing of this manuscript can be found at https://github.com/dholab/E484T-visualizations. Additional data from intermediate stages of our analysis are available upon reasonable request to the authors.

https://github.com/dholab/E484T-visualizations

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted April 12, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
Peter J. Halfmann, Nicholas R. Minor, Luis A. Haddock III, Robert Maddox, Gage K. Moreno, Katarina M. Braun, David A. Baker, Kasen K. Riemersa, Ankur Prasad, Kirsten J. Alman, Matthew C. Lambert, Kelsey Florek, Allen Bateman, Ryan Westergaard, Nasia Safdar, Dave R. Andes, Yoshihiro Kawaoka, Madiha Fida, Joseph D. Yao, Thomas C. Friedrich, David H. O’Connor
medRxiv 2022.04.11.22272784; doi: https://doi.org/10.1101/2022.04.11.22272784
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
Peter J. Halfmann, Nicholas R. Minor, Luis A. Haddock III, Robert Maddox, Gage K. Moreno, Katarina M. Braun, David A. Baker, Kasen K. Riemersa, Ankur Prasad, Kirsten J. Alman, Matthew C. Lambert, Kelsey Florek, Allen Bateman, Ryan Westergaard, Nasia Safdar, Dave R. Andes, Yoshihiro Kawaoka, Madiha Fida, Joseph D. Yao, Thomas C. Friedrich, David H. O’Connor
medRxiv 2022.04.11.22272784; doi: https://doi.org/10.1101/2022.04.11.22272784

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (502)
  • Anesthesia (110)
  • Cardiovascular Medicine (1234)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (530)
  • Epidemiology (10015)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2449)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1638)
  • Health Policy (751)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11862)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2278)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (535)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4829)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (651)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)